A citation-based method for searching scientific literature

Iván Márquez-Rodas, Sara López-Tarruella, Yolanda Jerez, Mercedes Cavanagh, Sara Custodio, Daniel López-Trabada, Beatriz Moya, Sara Pérez, Ana B Rupérez, Miguel Martín. J Genet Couns 2014
Times Cited: 3







List of co-cited articles
9 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Family history record and hereditary cancer risk perception according to National Cancer Institute criteria in a Spanish medical oncology service: a retrospective study.
Iván Márquez-Rodas, Daniel López-Trabada, Ana Belén Rupérez Blanco, Sara Custodio Cabello, María Isabel Peligros Gómez, María Orera Clemente, Felipe A Calvo, Miguel Martín. Oncology 2012
5
100

Identification and referral of families at high risk for cancer susceptibility.
Kevin M Sweet, Terry L Bradley, Judith A Westman. J Clin Oncol 2002
125
66

Association of risk-reducing surgery in BRCA1 or BRCA2 mutation carriers with cancer risk and mortality.
Susan M Domchek, Tara M Friebel, Christian F Singer, D Gareth Evans, Henry T Lynch, Claudine Isaacs, Judy E Garber, Susan L Neuhausen, Ellen Matloff, Rosalind Eeles,[...]. JAMA 2010
824
66

Olaparib maintenance therapy in platinum-sensitive relapsed ovarian cancer.
Jonathan Ledermann, Philipp Harter, Charlie Gourley, Michael Friedlander, Ignace Vergote, Gordon Rustin, Clare Scott, Werner Meier, Ronnie Shapira-Frommer, Tamar Safra,[...]. N Engl J Med 2012
66

Contralateral mastectomy and survival after breast cancer in carriers of BRCA1 and BRCA2 mutations: retrospective analysis.
Kelly Metcalfe, Shelley Gershman, Parviz Ghadirian, Henry T Lynch, Carrie Snyder, Nadine Tung, Charmaine Kim-Sing, Andrea Eisen, William D Foulkes, Barry Rosen,[...]. BMJ 2014
151
66

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and advanced breast cancer: a proof-of-concept trial.
Andrew Tutt, Mark Robson, Judy E Garber, Susan M Domchek, M William Audeh, Jeffrey N Weitzel, Michael Friedlander, Banu Arun, Niklas Loman, Rita K Schmutzler,[...]. Lancet 2010
66

DNA-Repair Defects and Olaparib in Metastatic Prostate Cancer.
Joaquin Mateo, Suzanne Carreira, Shahneen Sandhu, Susana Miranda, Helen Mossop, Raquel Perez-Lopez, Daniel Nava Rodrigues, Dan Robinson, Aurelius Omlin, Nina Tunariu,[...]. N Engl J Med 2015
66

Germline BRCA testing is moving from cancer risk assessment to a predictive biomarker for targeting cancer therapeutics.
L Moreno, C Linossi, I Esteban, N Gadea, E Carrasco, S Bonache, S Gutiérrez-Enríquez, C Cruz, O Díez, J Balmaña. Clin Transl Oncol 2016
15
66

SEOM clinical guidelines in Hereditary Breast and ovarian cancer.
G Llort, I Chirivella, R Morales, R Serrano, A Beatriz Sanchez, A Teulé, E Lastra, J Brunet, J Balmaña, B Graña. Clin Transl Oncol 2015
45
66

Genetic risk assessment for women with epithelial ovarian cancer: referral patterns and outcomes in a university gynecologic oncology clinic.
Sue V Petzel, Rachel Isaksson Vogel, Tracy Bensend, Anna Leininger, Peter A Argenta, Melissa A Geller. J Genet Couns 2013
30
33

Barriers to and motivations for physician referral of patients to cancer genetics clinics.
Carrie F Prochniak, Lisa J Martin, Erin M Miller, Sara C Knapke. J Genet Couns 2012
24
33


Adverse events in cancer genetic testing: medical, ethical, legal, and financial implications.
Karina L Brierley, Erica Blouch, Whitney Cogswell, Jeanne P Homer, Debbie Pencarinha, Christine L Stanislaw, Ellen T Matloff. Cancer J 2012
66
33



Awareness and utilization of BRCA1/2 testing among U.S. primary care physicians.
Cecelia A Bellcross, Katherine Kolor, Katrina A B Goddard, Ralph J Coates, Michele Reyes, Muin J Khoury. Am J Prev Med 2011
111
33


Family history and women with ovarian cancer: is it asked and does it matter?: An observational study.
Anne Lanceley, Zara Eagle, Gemma Ogden, Sue Gessler, Khalil Razvi, Jonathan A Ledermann, Lucy Side. Int J Gynecol Cancer 2012
22
33

Efficient identification and referral of low-income women at high risk for hereditary breast cancer: a practice-based approach.
G Joseph, C Kaplan, J Luce, R Lee, S Stewart, C Guerra, R Pasick. Public Health Genomics 2012
18
33



A cancer genetics toolkit improves access to genetic services through documentation and use of the family history by primary-care clinicians.
Maren T Scheuner, Alison B Hamilton, Jane Peredo, Taylor J Sale, Colletta Austin, Stuart C Gilman, M Scott Bowen, Caroline Lubick Goldzweig, Martin Lee, Brian S Mittman,[...]. Genet Med 2014
31
33

Estimating the referral rate for cancer genetic assessment from a systematic review of the evidence.
C Featherstone, A Colley, K Tucker, J Kirk, M B Barton. Br J Cancer 2007
10
33

Genetic cancer risk assessment and counseling: recommendations of the national society of genetic counselors.
Angela Trepanier, Mary Ahrens, Wendy McKinnon, June Peters, Jill Stopfer, Sherry Campbell Grumet, Susan Manley, Julie O Culver, Ronald Acton, Joy Larsen-Haidle,[...]. J Genet Couns 2004
143
33

A self-administered family history questionnaire improves identification of women who warrant referral to genetic counseling for hereditary cancer risk.
Tilley Jenkins Vogel, Kyrsten Stoops, Robin L Bennett, Margaret Miller, Elizabeth M Swisher. Gynecol Oncol 2012
16
33

Reported referral for genetic counseling or BRCA 1/2 testing among United States physicians: a vignette-based study.
Katrina F Trivers, Laura-Mae Baldwin, Jacqueline W Miller, Barbara Matthews, C Holly A Andrilla, Denise M Lishner, Barbara A Goff. Cancer 2011
76
33

Concise handbook of familial cancer susceptibility syndromes - second edition.
Noralane M Lindor, Mary L McMaster, Carl J Lindor, Mark H Greene. J Natl Cancer Inst Monogr 2008
171
33

Does the diagnosis of breast or ovarian cancer trigger referral to genetic counseling?
C Bethan Powell, Ramey Littell, Elizabeth Hoodfar, Fiona Sinclair, Alice Pressman. Int J Gynecol Cancer 2013
37
33

Errors in delivery of cancer genetics services: implications for practice.
Karina L Brierley, Danielle Campfield, Whitney Ducaine, Lindsay Dohany, Talia Donenberg, Kristen Shannon, Robin C Schwartz, Ellen T Matloff. Conn Med 2010
65
33

Keeping it simple: genetics referrals for all invasive serous ovarian cancers.
R Demsky, J McCuaig, M Maganti, K J Murphy, B Rosen, S R Armel. Gynecol Oncol 2013
38
33

Comparison of the clinical prediction model PREMM(1,2,6) and molecular testing for the systematic identification of Lynch syndrome in colorectal cancer.
Fay Kastrinos, Ewout W Steyerberg, Judith Balmaña, Rowena Mercado, Steven Gallinger, Robert Haile, Graham Casey, John L Hopper, Loic LeMarchand, Noralane M Lindor,[...]. Gut 2013
38
33

Update multiple endocrine neoplasia type 2.
Friedhelm Raue, Karin Frank-Raue. Fam Cancer 2010
84
33

American Society of Clinical Oncology policy statement: the role of the oncologist in cancer prevention and risk assessment.
Robin T Zon, Elizabeth Goss, Victor G Vogel, Rowan T Chlebowski, Ismail Jatoi, Mark E Robson, Dana S Wollins, Judy E Garber, Powel Brown, Barnett S Kramer. J Clin Oncol 2009
41
33

Eligibility criteria in private and public coverage policies for BRCA genetic testing and genetic counseling.
Grace Wang, Mary S Beattie, Ninez A Ponce, Kathryn A Phillips. Genet Med 2011
30
33

One to 2-year surveillance intervals reduce risk of colorectal cancer in families with Lynch syndrome.
Hans F A Vasen, Mohamed Abdirahman, Richard Brohet, Alexandra M J Langers, Jan H Kleibeuker, Mariette van Kouwen, Jan Jacob Koornstra, Henk Boot, Annemieke Cats, Evelien Dekker,[...]. Gastroenterology 2010
160
33

Oral poly(ADP-ribose) polymerase inhibitor olaparib in patients with BRCA1 or BRCA2 mutations and recurrent ovarian cancer: a proof-of-concept trial.
M William Audeh, James Carmichael, Richard T Penson, Michael Friedlander, Bethan Powell, Katherine M Bell-McGuinn, Clare Scott, Jeffrey N Weitzel, Ana Oaknin, Niklas Loman,[...]. Lancet 2010
932
33

Corrigendum: Clinical Application of Multigene Panels: Challenges of Next-Generation Counseling and Cancer Risk Management.
Thomas Paul Slavin, Mariana Niell-Swiller, Ilana Solomon, Bita Nehoray, Christina Rybak, Kathleen R Blazer, Jeffrey N Weitzel. Front Oncol 2015
10
33

Hereditary colon cancer syndromes.
Manish Gala, Daniel C Chung. Semin Oncol 2011
29
33

Changes of Socio-demographic data of clients seeking genetic counseling for hereditary breast and ovarian cancer due to the "Angelina Jolie Effect".
Christine Staudigl, Georg Pfeiler, Katharina Hrauda, Romana Renz, Andreas Berger, Renate Lichtenschopf, Christian F Singer, Muy-Kheng M Tea. BMC Cancer 2016
16
33


Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer.
H J Järvinen, M Aarnio, H Mustonen, K Aktan-Collan, L A Aaltonen, P Peltomäki, A De La Chapelle, J P Mecklin. Gastroenterology 2000
919
33

Selecting Patients with Ovarian Cancer for Germline BRCA Mutation Testing: Findings from Guidelines and a Systematic Literature Review.
Diana M Eccles, Judith Balmaña, Joe Clune, Birgit Ehlken, Annegret Gohlke, Ceri Hirst, Danielle Potter, Claudia Schroeder, Jerzy E Tyczynski, Encarnacion B Gomez Garcia. Adv Ther 2016
30
33

Health insurance and discrimination concerns and BRCA1/2 testing in a clinic population.
Emily A Peterson, Kara J Milliron, Karen E Lewis, Susan D Goold, Sofia D Merajver. Cancer Epidemiol Biomarkers Prev 2002
92
33

Clinical Actionability of Multigene Panel Testing for Hereditary Breast and Ovarian Cancer Risk Assessment.
Andrea Desmond, Allison W Kurian, Michele Gabree, Meredith A Mills, Michael J Anderson, Yuya Kobayashi, Nora Horick, Shan Yang, Kristen M Shannon, Nadine Tung,[...]. JAMA Oncol 2015
197
33

Salpingo-oophorectomy and the risk of ovarian, fallopian tube, and peritoneal cancers in women with a BRCA1 or BRCA2 Mutation.
Amy Finch, Mario Beiner, Jan Lubinski, Henry T Lynch, Pal Moller, Barry Rosen, Joan Murphy, Parviz Ghadirian, Eitan Friedman, William D Foulkes,[...]. JAMA 2006
384
33


Response to neoadjuvant therapy with cisplatin in BRCA1-positive breast cancer patients.
T Byrski, T Huzarski, R Dent, J Gronwald, D Zuziak, C Cybulski, J Kladny, B Gorski, J Lubinski, S A Narod. Breast Cancer Res Treat 2009
220
33

Disparities in BRCA testing: when insurance coverage is not a barrier.
Windy Olaya, Pamela Esquivel, Jan H Wong, John W Morgan, Adam Freeberg, Sharmila Roy-Chowdhury, Sharon S Lum. Am J Surg 2009
34
33

Clinical evaluation of a multiple-gene sequencing panel for hereditary cancer risk assessment.
Allison W Kurian, Emily E Hare, Meredith A Mills, Kerry E Kingham, Lisa McPherson, Alice S Whittemore, Valerie McGuire, Uri Ladabaum, Yuya Kobayashi, Stephen E Lincoln,[...]. J Clin Oncol 2014
303
33

Rescreening for genetic mutations using multi-gene panel testing in patients who previously underwent non-informative genetic screening.
Melissa K Frey, Sarah H Kim, Rebecca Yee Bassett, Jessica Martineau, Emily Dalton, Jing-Yi Chern, Stephanie V Blank. Gynecol Oncol 2015
26
33


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.